Literature DB >> 32140979

Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases.

Tiffany R Butterfield1, Alan L Landay2, Joshua J Anzinger3,4.   

Abstract

PURPOSE OF REVIEW: An increasing body of evidence indicates that persons living with HIV (PLWH) display dysfunctional immunometabolism. Here, we provide an updated review of this topic and its relationship to HIV-associated immune stimuli and age-related disease. RECENT
FINDINGS: HIV infection alters immunometabolism by increasing reliance on aerobic glycolysis for energy and productive infection and repurposing oxidative phosphorylation machinery for immune cell proliferation and survival. Recent studies in PLWH with diabetes mellitus or cardiovascular disease have identified an association with elevated T cell and monocyte glucose metabolism, respectively. Immunometabolic dysfunction has also been observed in PLWH in frailty and additional studies suggest a role for immunometabolism in non-AIDS defining cancers and neurocognitive disease. There is a plethora of HIV-associated immune stimuli that could drive immunometabolic dysfunction and age-related disease in PLWH, but studies directly examining their relationship are lacking. Immunometabolic dysfunction is characteristic of HIV infection and is a potential link between HIV-associated stimuli and age-related comorbidities.

Entities:  

Keywords:  Antiretroviral therapy; Glycolysis; HIV; Immune activation; Immunometabolism; Oxidative phosphorylation

Mesh:

Year:  2020        PMID: 32140979      PMCID: PMC8760627          DOI: 10.1007/s11904-020-00484-4

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  132 in total

1.  Glucose transporter 1-expressing proinflammatory monocytes are elevated in combination antiretroviral therapy-treated and untreated HIV+ subjects.

Authors:  Clovis S Palmer; Joshua J Anzinger; Jingling Zhou; Maelenn Gouillou; Alan Landay; Anthony Jaworowski; Joseph M McCune; Suzanne M Crowe
Journal:  J Immunol       Date:  2014-11-03       Impact factor: 5.422

2.  Microbiota-Dependent Marker TMAO is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT.

Authors:  Andreas Knudsen; Thomas Emil Christensen; Kristina Thorsteinsson; Adam Ali Ghotbi; Philip Hasbak; Anne-Mette Lebech; Susanne Dam Nielsen; Johannes Roksund Hov; Rolf Berge; Rasmus Sejersten Ripa; Andreas Kjær; Marius Trøseid
Journal:  J Acquir Immune Defic Syndr       Date:  2016-08-01       Impact factor: 3.731

3.  Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection.

Authors:  Kristine M Erlandson; Derek K Ng; Lisa P Jacobson; Joseph B Margolick; Adrian S Dobs; Frank J Palella; Jordan E Lake; Hanhvy Bui; Lawrence Kingsley; Todd T Brown
Journal:  J Infect Dis       Date:  2017-01-15       Impact factor: 5.226

4.  Interplay between gut microbiota metabolism and inflammation in HIV infection.

Authors:  Jorge F Vázquez-Castellanos; Sergio Serrano-Villar; Nuria Jiménez-Hernández; María Dolores Soto Del Rio; Sara Gayo; David Rojo; Manuel Ferrer; Coral Barbas; Santiago Moreno; Vicente Estrada; Tomas Rattei; Amparo Latorre; Andrés Moya; María José Gosalbes
Journal:  ISME J       Date:  2018-05-23       Impact factor: 10.302

5.  Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function.

Authors:  Will Bailis; Justin A Shyer; Jun Zhao; Juan Carlos Garcia Canaveras; Fatimah J Al Khazal; Rihao Qu; Holly R Steach; Piotr Bielecki; Omair Khan; Ruaidhri Jackson; Yuval Kluger; Louis J Maher; Joshua Rabinowitz; Joe Craft; Richard A Flavell
Journal:  Nature       Date:  2019-06-19       Impact factor: 49.962

6.  Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.

Authors:  S R Ostrowski; T L Katzenstein; B K Pedersen; J Gerstoft; H Ullum
Journal:  Scand J Immunol       Date:  2008-12       Impact factor: 3.487

7.  HIV infection is associated with an increased risk for lung cancer, independent of smoking.

Authors:  Gregory D Kirk; Christian Merlo; Peter O' Driscoll; Shruti H Mehta; Noya Galai; David Vlahov; Jonathan Samet; Eric A Engels
Journal:  Clin Infect Dis       Date:  2007-05-22       Impact factor: 9.079

8.  Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patients.

Authors:  Pierre Duffau; Linda Wittkop; Estibaliz Lazaro; Fabien le Marec; Céline Cognet; Patrick Blanco; Jean-François Moreau; Frédéric-Antoine Dauchy; Charles Cazanave; Marie-Anne Vandenhende; Fabrice Bonnet; Rodolphe Thiebaut; Isabelle Pellegrin
Journal:  AIDS       Date:  2015-10-23       Impact factor: 4.177

9.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

10.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

View more
  6 in total

Review 1.  Innate metabolic responses against viral infections.

Authors:  Clovis S Palmer
Journal:  Nat Metab       Date:  2022-10-20

2.  Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls.

Authors:  Andreas D Knudsen; Randa Bouazzi; Shoaib Afzal; Marco Gelpi; Thomas Benfield; Julie Høgh; Magda Teresa Thomsen; Marius Trøseid; Børge G Nordestgaard; Susanne D Nielsen
Journal:  BMC Infect Dis       Date:  2022-05-11       Impact factor: 3.667

3.  Central nervous system (CNS) transcriptomic correlates of human immunodeficiency virus (HIV) brain RNA load in HIV-infected individuals.

Authors:  Pietro Paolo Sanna; Yu Fu; Eliezer Masliah; Celine Lefebvre; Vez Repunte-Canonigo
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.996

Review 4.  Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIV.

Authors:  Caian L Vinhaes; Mariana Araujo-Pereira; Rafael Tibúrcio; Juan M Cubillos-Angulo; Fernanda O Demitto; Kevan M Akrami; Bruno B Andrade
Journal:  Life (Basel)       Date:  2021-01-18

5.  Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.

Authors:  Lauren F Collins; Anandi N Sheth; C Christina Mehta; Susanna Naggie; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Seble Kassaye; Tonya N Taylor; Margaret A Fischl; Adaora A Adimora; Mirjam-Colette Kempf; Frank J Palella; Phyllis C Tien; Ighovwerha Ofotokun
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

6.  Increased prevalence of hypertension among people living with HIV: where to begin?

Authors:  Aldrey Nascimento Costa; Fernando Val; Álvaro Elias Macedo; Nadia Cubas-Vega; Paola López Del Tejo; Marly M Marques; Aristóteles Comte de Alencar Filho; Marcus Vinicius Guimarães de Lacerda
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.